_________________
August 2, 2021 | ValGenesis, Inc., the market leader in Enterprise Validation Lifecycle Management Systems (VLMS), today announced the appointment of Kevin O’Donnell as Chief Financial Officer, effective August 2, 2021.
A top Italian life sciences company has chosen to implement ValGenesis’ 100% paperless Validation Lifecycle Management System (VLMS) to manage its corporate validation lifecycle process.
Digitization of backend processes and workflow automation is a rapidly emerging area of growth for healthcare and life sciences companies. As a market leader, ValGenesis offers a fit-for-purpose platform for validation lifecycle management, resulting in significant cost and time efficiencies for global, compliance focused organizations.
A U.S. based cell therapies company has selected ValGenesis VLMS – the industry’s most trusted electronic validation lifecycle management system – to digitize multiple corporate validation lifecycle processes across the organization.
An international biosciences company has selected ValGenesis to digitize the validation processes for its products and solutions through a single instance of ValGenesis VLMS with multilingual support that would be accessed by thousands of life science organizations across 40 countries.
A pioneering gene therapy company has selected ValGenesis VLMS for its remote validation capability, and for its ability to enable efficient change and risk management to help the company achieve better control over these processes.
The scalable and configurable nature of ValGenesis VLMS will enable Biocon Biologics’ quality leaders to monitor the validation status of their instruments, equipment, software systems, and processes remotely and in real time across multiple sites.
ValGenesis VLMS enables remote validation execution, preventing interruptions in the company’s validation programs especially in these times when their workforce is predominantly remote and/or working from home. The system is configurable and scalable to facilitate implementation at a single site and expansion across multiple sites in the future.
A global Top 5 life science organization has chosen ValGenesis VLMS for its depth of functionality and ability to meet all the company’s business needs. ValGenesis will manage the validation of the company’s Labs with initial deployment across two sites.
ValGenesis VLMS will help the company achieve more efficient change control management across their IT Business systems, and enable control and flexibility in assigning and managing the various validation activities.